Biotech SF
San Francisco Bay Area biotech stories.
Monday, December 20, 2010
Gilead to buy Palo Alto's Arresto, IPF antibody drug maker, for $225M
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment